Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Lederer

Showing results (131-140 of 219) with videos related to

Pageof 22
Sort By:
The European Respiratory Journal|September 21, 2023
Dupilumab leads to better-controlled asthma and quality of life in children: the VOYAGE studyAlessandro G Fiocchi, Wanda Phipatanakul, Robert S Zeiger, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|May 28, 2008
Assessment of kidney function in lung transplant candidatesNadine Al-Naamani, Omar H Maarouf, Vivek N Ahya, et al.
Annals of the American Thoracic Society|June 13, 2020
Thoracic Visceral Adipose Tissue Area and Pulmonary Hypertension in Lung Transplant Candidates. The Lung Transplant Body Composition StudyNadine Al-Naamani, Hao-Min Pan, Michaela R Anderson, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|August 3, 2014
A consensus document for the selection of lung transplant candidates: 2014--an update from the Pulmonary Transplantation Council of the International Society for Heart and Lung TransplantationDavid Weill, Christian Benden, Paul A Corris, et al.
Respiratory Medicine|January 25, 2024
Dupilumab sustains lung function improvements in patients with moderate-to-severe asthmaAlberto Papi, Mario Castro, Jonathan Corren, et al.
Circulation|May 20, 2011
Randomized clinical trial of aspirin and simvastatin for pulmonary arterial hypertension: ASA-STATSteven M Kawut, Emilia Bagiella, David J Lederer, et al.
Chest|April 10, 2015
Sensitivity Analyses of the Change in FVC in a Phase 3 Trial of Pirfenidone for Idiopathic Pulmonary FibrosisDavid J Lederer, Williamson Z Bradford, Elizabeth A Fagan, et al.
The Journal of Allergy and Clinical Immunology|January 25, 2024
Blood eosinophils and fractional exhaled nitric oxide are prognostic and predictive biomarkers in childhood asthmaLeonard B Bacharier, Ian D Pavord, Jorge F Maspero, et al.
Annals of the American Thoracic Society|January 24, 2015
Interleukin-6 and tumor necrosis factor-α are associated with quality of life-related symptoms in pulmonary arterial hypertensionLea Ann Matura, Corey E Ventetuolo, Harold I Palevsky, et al.
The Lancet. Respiratory Medicine|October 3, 2019
Pamrevlumab, an anti-connective tissue growth factor therapy, for idiopathic pulmonary fibrosis (PRAISE): a phase 2, randomised, double-blind, placebo-controlled trialLuca Richeldi, Evans R Fernández Pérez, Ulrich Costabel, et al.
Pageof 22

Showing results (131-140 of 219) with videos related to

Sort By:
Pageof 22
The European Respiratory Journal|September 21, 2023
Dupilumab leads to better-controlled asthma and quality of life in children: the VOYAGE studyAlessandro G Fiocchi, Wanda Phipatanakul, Robert S Zeiger, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|May 28, 2008
Assessment of kidney function in lung transplant candidatesNadine Al-Naamani, Omar H Maarouf, Vivek N Ahya, et al.
Annals of the American Thoracic Society|June 13, 2020
Thoracic Visceral Adipose Tissue Area and Pulmonary Hypertension in Lung Transplant Candidates. The Lung Transplant Body Composition StudyNadine Al-Naamani, Hao-Min Pan, Michaela R Anderson, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|August 3, 2014
A consensus document for the selection of lung transplant candidates: 2014--an update from the Pulmonary Transplantation Council of the International Society for Heart and Lung TransplantationDavid Weill, Christian Benden, Paul A Corris, et al.
Respiratory Medicine|January 25, 2024
Dupilumab sustains lung function improvements in patients with moderate-to-severe asthmaAlberto Papi, Mario Castro, Jonathan Corren, et al.
Circulation|May 20, 2011
Randomized clinical trial of aspirin and simvastatin for pulmonary arterial hypertension: ASA-STATSteven M Kawut, Emilia Bagiella, David J Lederer, et al.
Chest|April 10, 2015
Sensitivity Analyses of the Change in FVC in a Phase 3 Trial of Pirfenidone for Idiopathic Pulmonary FibrosisDavid J Lederer, Williamson Z Bradford, Elizabeth A Fagan, et al.
The Journal of Allergy and Clinical Immunology|January 25, 2024
Blood eosinophils and fractional exhaled nitric oxide are prognostic and predictive biomarkers in childhood asthmaLeonard B Bacharier, Ian D Pavord, Jorge F Maspero, et al.
Annals of the American Thoracic Society|January 24, 2015
Interleukin-6 and tumor necrosis factor-α are associated with quality of life-related symptoms in pulmonary arterial hypertensionLea Ann Matura, Corey E Ventetuolo, Harold I Palevsky, et al.
The Lancet. Respiratory Medicine|October 3, 2019
Pamrevlumab, an anti-connective tissue growth factor therapy, for idiopathic pulmonary fibrosis (PRAISE): a phase 2, randomised, double-blind, placebo-controlled trialLuca Richeldi, Evans R Fernández Pérez, Ulrich Costabel, et al.
Pageof 22